| Abstrakt: |
Keywords: Breast Cancer Screening; Cancer; Chemistry; Diagnostics and Screening; Emerging Technologies; Engineering; Health and Medicine; Immunologic Receptors; Integrins; Internal Medicine; Membrane Proteins; Molecular Imaging; Nanotechnology; Nuclear Medicine; Oncology; Risk and Prevention; Society of Nuclear Medicine and Molecular Imaging EN Breast Cancer Screening Cancer Chemistry Diagnostics and Screening Emerging Technologies Engineering Health and Medicine Immunologic Receptors Integrins Internal Medicine Membrane Proteins Molecular Imaging Nanotechnology Nuclear Medicine Oncology Risk and Prevention Society of Nuclear Medicine and Molecular Imaging 473 473 1 06/19/23 20230620 NES 230620 2023 JUN 20 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Reston, Virginia-The SNMMI Mars Shot Research Fund is excited to announce that Julie Sutcliffe, PhD, professor of internal medicine and biomedical engineering, University of California-Davis, has been selected as the recipient of a $500,000 grant from the 2023 Mars Shot Fund. Breast Cancer Screening, Cancer, Chemistry, Diagnostics and Screening, Emerging Technologies, Engineering, Health and Medicine, Immunologic Receptors, Integrins, Internal Medicine, Membrane Proteins, Molecular Imaging, Nanotechnology, Nuclear Medicine, Oncology, Risk and Prevention, Society of Nuclear Medicine and Molecular Imaging Sutcliffe's Mars Shot grant was awarded based on her proposal, "Evaluating the integrin avb6-targeted molecular imaging agent [68Ga]Ga DOTA-5G as a diagnostic for lobular breast cancer.". [Extracted from the article] |
